2014 annual financial data
Avalo Therapeutics 2014 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -17,115,565 USD and net income was -16,055,591 USD.
Operating cash flow was -15,518,349 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -17,115,565 USD
- Net income
- -16,055,591 USD
- Operating cash flow
- -15,518,349 USD